64 results
Page 3 of 4
6-K
EX-99.1
33safmc
12 Aug 21
Silence Therapeutics Reports Half-Year 2021 Results
4:30pm
6-K
EX-99.1
uc66wbe
7 Jun 21
Preclinical data at EHA support recently reported positive topline clinical data for SLN124 in healthy volunteers
7:15am
6-K
EX-99.1
lgxcsfl
25 May 21
Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment for Ongoing siRNA Collaboration
6:30am
6-K
EX-99.1
5sve3vyu513hwtuxzk6
19 May 21
Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers
6:30am
20-F/A
u8323cqu792
29 Apr 21
Annual report (foreign) (amended)
4:26pm
424B4
57xmngsn7qmqlhwg7
12 Apr 21
Prospectus supplement with pricing info
11:12am
424B4
ulihts736yy
12 Apr 21
Prospectus supplement with pricing info
11:11am
POS AM
3j8jk13n3jz 8tay
8 Apr 21
Prospectus update (post-effective amendment)
9:31am
POS AM
1ry lw7zn4o6h6
8 Apr 21
Prospectus update (post-effective amendment)
9:18am
20-F
lg7rdka
30 Mar 21
Annual report (foreign)
5:22pm
424B7
vz6mfx bpyzz7yvx8
15 Mar 21
Prospectus with selling stockholder info
10:07am
F-1/A
tmpyjorm5ciqfyr
11 Mar 21
Registration statement (foreign) (amended)
4:02pm
F-1
iob5c4eskee7jhy
8 Mar 21
Registration statement (foreign)
9:50pm
6-K
EX-99.1
bhx43kz7wpxeka2
5 Feb 21
Securities Purchase Agreement
9:40pm
6-K
EX-99.2
rvgs8hdhiahgzhsj8bc
5 Feb 21
Securities Purchase Agreement
9:40pm
POS AM
6jj3t4r
23 Sep 20
Prospectus update (post-effective amendment)
4:47pm
424B4
cmpjjuvb8jc1h4
8 Sep 20
Prospectus supplement with pricing info
7:31am
F-1
EX-10.5
48r48pec 7a5
20 Aug 20
Registration statement (foreign)
4:50pm
F-1
a41fa
20 Aug 20
Registration statement (foreign)
4:50pm
F-1
EX-10.6
nhoku
20 Aug 20
Registration statement (foreign)
4:50pm